This is the authors' abstract. We don't add key points for this paper.
Purpose: To study the prevalence of TEM-, SHV- and GES-type β-lactamases among Escherichia coli and Klebsiella pneumoniae strains having ceftazidime MICs higher than 2 mg/L. Methods: A total of 63 E. coli and 41 K. pneumoniae isolated from five different university hospitals were studied for the existence of TEM-, SHV- and GES-type β-lactamases. Susceptibility tests were carried out according to the criteria of National Committee for Clinical Laboratory Standards. MICs were obtained by agar dilution method. Existence of extended-spectrum β-lactamases (ESBLs) were assessed by double-disc synergy test (DDST). Existence of the above-mentioned β-lactamase genes were studied both by PCR with specific oligonucleotide primers and isoelectric focusing methods. Results: None of the isolates were carbapenem-resistant. DDSTs were positive in 50 (79.3%) and 33 (80.5%) of E. coli and K. pneumoniae, respectively. TEM gene was detected in 41 (65.1%) and 19 (46.3%), whereas SHV gene in 18 (28.6%) and 20 (48.8%) of E. coli and K. pneumoniae strains, respectively. GES genes were not detected. Conclusions: TEM and SHV genes are highly prevalent among ESBL-producing E. coli and K. pneumoniae, whereas GES-type ESBLs are absent and found not to be responsible of ceftazidime resistance in Turkish hospitals.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hoşoğlu et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: